| Initial BW (g) | Final BW (g) | PW (mg) | PI (mg/g) | % inhibition for PI |
---|
Sham C. | 251 ± 8.49 | 290 ± 11.55a | 509.8 ± 72.42a | 1.76 ± 0.23a | - |
BPH | 245 ± 8.94 | 234 ± 10.02b,* | 1564.67 ± 249b,* | 6.73 ± 1.34b,* | - |
Finasteride | 242 ± 15.71 | 269 ± 15.9a | 596.67 ± 77.18a,# | 2.23 ± 0.37a,# | 90.4 |
Alhagi (200) | 240 ± 4.42 | 265 ± 8.15a | 764.6 ± 115.37a,# | 2.89 ± 0.43a,# | 77.3 |
Alhagi (400) | 238 ± 16.41 | 275 ± 30.87a | 539 ± 91.76a,# | 1.97 ± 0.37a,# | 95.7 |
- Sham C sham control, BPH: positive control with benign prostatic hyperplasia, Finasteride: comparative control, the BPH animals receiving Finasteride with a dosage of 5Â mg/kg/day through oral gavages, and Alhagi (200) and Alhagi (400): the BPH animals receiving A. maurorum extract at a dosage of 200 and 400Â mg/kg/day through oral gavage for 28 successive days
- BW Body weight, PW Prostate weight, PI Prostatic index and % inhibition for PI: inhibition percentage for the prostatic index
- The values characterized by various letters in a column indicate a significant difference (p < 0.05). Furthermore, the values shown by a * sign indicate a significant difference of p < 0.0001 compared to the sham control, while the values with a # sign refer to a significant difference of p < 0.0001 compared to the BPH model. It is noteworthy that statistical analysis was not applicable to % inhibition for the prostatic index